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Embryonic stem cells (ESCs) can be maintained in the naïve state through inhibition of Mek1/
2 and Gsk3 (2i). A relevant effect of 2i is the inhibition of Cdk8/19, which are negative
regulators of the Mediator complex, responsible for the activity of enhancers. Inhibition of
Cdk8/19 (Cdk8/19i) stimulates enhancers and, similar to 2i, stabilizes ESCs in the naïve
state. Here, we use mass spectrometry to describe the molecular events (phosphoproteome,
proteome, and metabolome) triggered by 2i and Cdk8/19i on ESCs. Our data reveal wide-
spread commonalities between these two treatments, suggesting overlapping processes. We
find that post-transcriptional de-repression by both 2i and Cdk8/19i might support the
mitochondrial capacity of naive cells. However, proteome reprogramming in each treatment
is achieved by different mechanisms. Cdk8/19i acts directly on the transcriptional machinery,
activating key identity genes to promote the naïve program. In contrast, 2i stabilizes the naïve
circuitry through, in part, de-phosphorylation of downstream transcriptional effectors.
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A spectrum of transitory pluripotent states occurs duringearly development, and these can be captured in vitrothrough stimulation and blockade of specific pathways.
Leukemia inhibitory factor (LIF) together with inhibitors of
Mek1/2 and Gsk3 (2i)1 stabilize mouse embryonic stem cells
(mESCs) into the so-called naïve state, which closely resembles
the pre-implantation blastocyst2. Recently, we showed that naïve
pluripotency can also be stabilized by inducing a global upregu-
lation of key identity genes under the control of super-
enhancers3. This is achieved by inhibiting Cdk8/19 (Cdk8/19i)
and, thereby, relieving their negative effect on the Mediator
complex at enhancers. This suggests the existence of common
regulatory processes involved in the acquisition of naïve plur-
ipotency conferred by 2i-treatment or Cdk8/19i-treatment.
Understanding the pathways that regulate pluripotency is
important, especially for the derivation of naïve human ESCs4.
Compared to the more developmentally advanced states of the
post-implantation embryo (i.e., epiblast stem cells (EpiSCs),
known as primed state cells; or serum ESCs, which represent a
metastable state that fluctuates between primed and naïve plur-
ipotency), naïve ESCs express a set of transcription factors that
reinforce the pluripotency core factors while repressing lineage
specification genes5. Furthermore, while primed mEpiSCs and
hESCs are mainly glycolytic, naïve mESCs use oxidative
phosphorylation6. Another key feature of naïve cells is their
hypomethylated DNA7, although this has deleterious implications
upon long-term passages8. Importantly, a profound connection
between the metabolism of these cells and their epigenetic status
emerges as several metabolites have been found to determine
histone and DNA methylation levels9.
Despite the above-mentioned transcriptomic and epigenetic
insights, our understanding of pluripotency demands direct
analysis of protein-driven mechanisms, yet crucially, this has
been less explored10–12. Post-transcriptional regulation makes
mRNA levels an imperfect predictor of protein abundance in
mESCs13. Protein function is also rapidly altered by post-
translational modifications (PTMs), and methods used to stabi-
lize naïve cells target specific kinases, but how signaling is con-
nected to transcriptional control remains unclear. In this work,
we use mass spectrometry (MS) to dissect the establishment of
naïve pluripotency by two methods: blunting extracellular sig-
naling (2i) and stimulating enhancer transcription (Cdk8/19i).
Using an integrative strategy, we analyze three interconnected
regulatory layers. First, we profile the early phosphorylation
cascades that are triggered in response to these inhibitors (0–6 h)
to identify downstream effectors. Next, we monitor how protein
levels are tuned until naïve pluripotency is stabilized (0–14 days).
In addition, since the availability of metabolites can determine
their epigenetic status, we also probe the metabolome of cells
adapted to 2i or Cdk8/19i conditions. Our analyses reveal
missing links in the molecular roadmap from primed to naïve
pluripotency, and provide insights into the regulatory principles
of cell identity.
Results
Stabilization of naïve pluripotency by 2i and Cdk8/19i results
in similar proteome changes. To study proteome remodeling
during the stabilization of mESCs in the naïve state, we cultured a
panel of four mESC lines in standard serum/LIF (S/L) media.
Cells were then supplemented with either 2i or Cdk8/19i, col-
lected after 1, 2, 4, 7, 10, or 14 days of treatment, and subjected to
proteomic analysis (Fig. 1a). We chose to keep serum in all our
experimental conditions to better isolate and therefore study the
events regulated exclusively by the 2i and Cdk8/19i (Supple-
mentary Note 1). Nevertheless, we have previously shown that the
effects of Cdk8/19i in terms of morphology, homogenous
expression of Nanog-GFP and transcriptomic changes are highly
similar between serum-containing and serum-free media3. Using
isobaric labeling, a total of 4408 proteins were quantified in all
64 samples (Supplementary Fig. 1A), enabling us to accurately
monitor their temporal kinetics. PCA grouped all S/L samples
together, indicating the high reproducibility of our data (Fig. 1b
and Supplementary Fig. 1B). Cells treated for 1 day with either 2i
or Cdk8/19i clustered separately from S/L implying that, as early
as 24 h, their proteomes are already distinct from S/L, in agree-
ment with transcriptomics14. Of note, PCA trajectories suggested
that 2i and Cdk8/19i induced, to a certain extent, similar changes.
Upon 24 h of 2i and Cdk8/19i, 717 and 444 proteins increased
their expression compared to S/L respectively. Importantly, 219 of
them were common to both treatments (p.val = 8.8E−68) (Fig. 1c
and Supplementary Data 1). Conversely, proteins showing
opposite changes in 2i and Cdk8/19i were under-represented (p.
val = 2.7E−20) (Supplementary Fig. 1C). The number of changes
increased over time until day 7, when 47% of the proteome in 2i
and 37% in Cdk8/19i showed differential regulation. Throughout
all time-points, the regulated proteins overlapped significantly
between 2i and Cdk8/19i, with minor inverse changes (Fig. 1c and
Supplementary Fig. 1C). Next, we mapped transcriptomic sig-
natures of 2i-treated cells in our temporal-resolved proteome data
and found that mRNA changes showed overall concomitant
protein alterations after 48 h of 2i treatment, which were also
recapitulated, to some degree, in Cdk8/19i (Supplementary
Fig. 1D). Likewise, post-implantation genes correlated with
repressed proteins in both 2i and Cdk8/19i, whereas pre-
implantation genes (E3.5 and E4.5) showed positive trends
(Supplementary Fig. 1D). These results indicate that stabilization
of the naive state by these two chemical methods involves the
regulation of a large repertoire of proteins, some of which are
common to both strategies but also numerous proteins that are
regulated in a specific manner. In addition, both 2i and Cdk8/19i
recapitulate in vitro and in vivo transcriptomic signatures.
Several proteins involved in pluripotency (Tbx3, Klf4, and
Esrrb) and the naïve circuitry (Tfcp2l1) showed similar up-
regulation in 2i and Cdk8/19i. Lin28a, Dppa2, Dnmt3a, and Eras,
that are required in the primed state, were downregulated upon
inhibition of both pathways (Fig. 1d and Supplementary Fig. 1E).
We found that most of the proteome exhibited positive
correlation between 2i and Cdk8/19i, indicating that a large
fraction of the proteome undergoes similar temporal regulation
(Fig. 1e). We used unsupervised clustering and found 15 co-
regulated protein modules exhibiting various kinetics (Fig. 1f).
The two clusters containing more proteins, #7 (388 proteins) (r =
0.91; p.val = 0.039) and #15 (401 proteins) (r = 0.97; p.val =
0.0002), displayed remarkable similar patterns in 2i and Cdk8/
19i. Nevertheless, we also found clusters exhibiting different
dynamics between the treatments (#9, #12, #6) as well as clusters
of proteins that were only co-regulated in 2i (#3, #1, #2) (Fig. 1f).
Among the clusters containing upregulated proteins in both
treatments (#7), we found enrichment of proteins involved in
aerobic respiration and beta-oxidation (Fig. 1g). In contrast,
terms related to translation appeared enriched among proteins
with downregulated trends in both inhibitors (#15) (Fig. 1g). In
addition, proteins related to adherent junctions (#9) or RNA
processing (#3) were found in proteins displaying treatment-
specific kinetics. Together, our results indicate that acquisition of
naïve pluripotency by 2i and Cdk8/19i invokes multiple biological
processes (Supplementary Data 2). Some of these processes
displayed similar temporal kinetics, underscoring the presence of
shared mechanisms. However, our data also showed the existence
of proteins regulated exclusively by each treatment, indicating
unique regulatory mechanisms too.
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1 day 717 444 219 3 8.8 E-68
2 days 779 370 184 2.8 2.5 E-50
4 days 883 645 269 2.1 1.3 E-43
7 days 991 789 307 1.7 1.7 E-31
10 days 896 629 254 2 1.5 E-36
14 days 921 717 254 1.7 1.3 E-23
UP  2i UP Cdk8/19i
DOWN  2i DOWN Cdk8/19i
Common RF p.value
1 day 689 422 203 3.1 3.1 E-63
2 days 800 377 166 2.4 1.0 E-34
4 days 1005 663 332 2.2 2.5 E-64
7 days 1080 845 376 1.8 7.6 E-47
10 days 1013 663 270 1.8 2.9 E-29
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Fig. 1 Time-resolved proteome profiling of mESCs transitioning to the naïve state using 2i and Cdk8/19i. a Four different mESCs were grown in
Serum/LIF and transferred to Cdk8/19i or 2i supplemented media. Samples were recovered at different time points to measure the changes in
the phosphoproteome, proteome and metabolome. b Principal Component Analysis of the proteomes of mESCs treated with 2i (red) or Cdk8/19i
(blue) at different time points. c Differentially regulated proteins using a moderated t-test (limma two-sided, FDR < 5%) at the indicated time points.
The number of common proteins between 2i and Cdk8/19i is shown, together with the corresponding p.val calculated by a hypergeometric test
(RF indicates “Representation factor”). d Examples of changes in protein abundance for proteins related to pluripotency in response to 2i or Cdk8/19i
(N = 4 independent cell lines). Statistically significant changes using a moderated t-test (limma two-sided, FDR < 5%) relative to reference S/L
are indicated with an asterisk (p-value < 0.05). e Histogram of the Pearson correlation values (Pearson’s correlation test, two-tailed) between the
temporal proteins trends of 2i and Cdk8/19i. The 1228 proteins with r > 0.6 (dark gray) are displayed in the heatmap. f Gap statistics and K-means
classified the regulated proteome into 15 different clusters. The Pearson correlation and the corresponding p.val (Pearson’s correlation test, two-
tailed) between the centroids (thick lines) of 2i (red) and Cdk8/19i (blue) are shown. Color gradient in the line plots indicate proximity to the centroid
of the cluster. g Examples of GO-enriched terms in examples of clusters showing similar (#15, #7, #5) and different regulation (#9, #12, #6) between
2i and Cdk8/19i, as well as in clusters showing 2i-specific changes (#3, #1, #2). All the results from GO-enrichment analyses can be found in
Supplementary Data 2. Source data for Fig. 1b, e are provided as a Source Data file.
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Upregulation of proteostasis machineries during the transition
to naïve pluripotency. The most upregulated protein after 14 days
of 2i, Gabarapl2, was also the highest change in Cdk8/19i (Fig. 2a
and Supplementary Data 1). Gabarapl2 is involved in autophagy, a
process that has multiple links to pre-implantation15, diapause16,
and pluripotency17. The master transcription factor of autophagy
Tfe3 rapidly translocates to the nucleus in response to 2i18, and we
have shown that Cdk8/19i recapitulates this event3. Tfe3, together
with Tfeb and Mitf, belong to the MiTF/Tfe family that bind the
CLEAR elements present in the promoters of lysosomal biogenesis
genes19,20. We then examined the protein dynamics of the MiTF/
Tfe target genes in our data. Several lysosomal hydrolases such as
Ctsb, Glb1, Asah1, Ppt1, and Scpep1 increased in both 2i and
Cdk8/19i cultures compared to reference S/L (Fig. 2a). However,
the expression of CLEAR-box proteins was more significant in 2i.
Likewise, 2i, but not Cdk8/19i, increased the abundance of all the
subunits of the V-ATPase involved in the acidification of the
lysosomal lumen (Fig. 2a). We found similar trends in other 2i
published data sets (Supplementary Fig. 2C). To understand these
differential changes in 2i and Cdk8/19i, we checked the levels of
the MiTF/Tfe factors. Tfe3 protein levels decreased in response to
both drugs, probably reflecting the selective degradation of its
cytoplasmic form21 (Fig. 2a). Tfeb on the other hand did not
show significant changes (Fig. 2a). However, Mitf mRNA expres-
sion was remarkably different: 2i increased its levels 6-fold whereas
it remained unaltered in Cdk8/19i (Supplementary Fig. 2A). In
agreement with our data, Mitf is reported to regulate the expres-
sion of the V-ATPase pump22 and it increases upon ERK
inhibition23. Further, we found increased levels of LC3-II by
western blot (Supplementary Fig. 2B), which could reflect either
enhanced autophagosome synthesis or decreased autophagosome
degradation. We noticed however that this increase was more
evident in 2i than in Cdk8/19i, which might explain some of the
proteomic differences found in autophagy components between
both treatments. Therefore, our results show that naive cells
upregulate several autophagic components, likely through control
of members of the MiTF/Tfe family.
Unlike degradation of autophagy, the ubiquitin-proteasome
system (UPS) is the major degradation pathway for short-lived
proteins. Our data revealed a co-regulation of proteasome
subunits only in 2i (Cluster #2, q.val = 1.2E−14) (Supplementary
Data 2). Within 48 h, a transitory increase in the 20S and 19S
particles was found with the exception of the lid subunits that
remained unaltered (Fig. 2b). Interestingly, the signalosome
COP9 complex, that has been proposed to replace the lid in the
formation of specialized proteasomes24, exhibited a similar
transient kinetic (Fig. 2b). After 4 days, the proteasome and
COP9, including several assembly factors, decreased, suggesting a
rapid induction of these complexes followed by their disassembly/
degradation (Fig. 2b). Besides autophagy and the UPS, chaper-
ones also control proteome homeostasis. We found that the
chaperonin TRiC/CCT and Prefoldin complexes were tightly co-
regulated with the proteasome (Fig. 2b). Using a recent
proteome-wide co-regulation analysis25, we confirmed that all
these macromolecular machineries are frequently co-regulated
(Supplementary Fig. 2D, E). Interestingly, cluster#3 in 2i, which
mainly contained nuclear proteins (q.val = 1.18E−65), displayed
an opposite kinetic to the proteostasis machinery (r = −0.94,
p.val = 1.4E−3) (Fig. 1f). Rapid degradation of nuclear proteins
has been postulated as a mechanism for gene expression control,
and all these complexes have been found in active genomic
regions26,27. Nonetheless, whether the concerted regulation of
these macromolecular complexes is linked to the degradation of
nuclear proteins will require further experimentation.
Prevalent post-transcriptional regulation in naïve pluripotency.
Another wave of proteome remodeling occurred around 4–7 days































SL 1 2 4 7 10 14
days
SL 1 2 4 7 10 14
days
SL 1 2 4 7 10 14
days
SL 1 2 4 7 10 14
days
Proteasome subunits COP9-signalosome and
USP14
CLEAR network
SL 1 2 4 7 10 14
days





































































































SL 1 2 4 7 10 14
days
SL 1 2 4 7 10 14
days
SL 1 2 4 7 10 14
days





Fig. 2 Differential regulation of the autophagy and proteolysis machinery. Heatmaps showing the 2i-time and Cdk8/19i-time dependent protein changes
for several components involved in autophagy (a) as well as protein complexes involved in proteostasis (b). Source data are provided as a Source Data file.
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remained increased afterwards (cluster#7) (Fig. 1f). Importantly,
these changes were highly synchronous in 2i and Cdk8/19i
(p.val = 0.039) indicating a central role for these proteins in naïve
pluripotency. GO analyses revealed a massive representation of
mitochondrial proteins (q.val= 4.9E−72) (Supplementary Data 2)
(Fig. 1g). We found a clear increase in all major electron transport
chain (ETC) complexes with the exception of complex-I that was
primarily upregulated in 2i (Fig. 3a). Complex I is the entry point
of the redox process and generates up to 40% of the ATP in the
cell. Therefore, we questioned whether this difference in the
stoichiometry of ETC complexes had any impact on ATP pro-
duction. In agreement with our proteomic results, we found that 2i
cells were more sensitive to rotenone, a potent complex I inhibitor,
than S/L cells, indicating that they rely on Complex I as the main
source for ATP (Fig. 3b). On the other hand, Cdk8/19i treated
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Fig. 3 Degradation of LIN28a in 2i and Cdk8/19i releases target mRNAs and enhances translation of mitochondrial components. a Protein levels across
time for the electron transport chain subunits. b Rotenone induced dose-dependent cytotoxicity on S/L, 2i and Cdk8/19i mESCs in two different cell lines
(E14 and V6.4). Data is expressed as percentage of ATP in non‐treated wells, and it is shown as mean (n = 3 technical replicates) ± st dev. c Correlation of
transcriptomic and proteomic changes for 2i (red) and Cdk8/19i (blue) relative to S/L. In black, mitochondrial proteins (UniProt). Boxplots represent the
distribution of transcriptomic or proteomic log2 ratios of 2i (red) or Cdk8/19i (blue) vs. SL for total proteins (n = 4093 proteins) and mitochondrial
proteins (black, n = 515 proteins). d Boxplots for protein (n = 4 independent cell lines) and mRNA (n = 3 biologically independent samples) ratios (2i or
Cdk8/19i vs. S/L) for all genes (light, n = 4093 proteins) and for proteins localized in the mitochondria (black, n = 515 proteins). Statistical significance
was calculated using a paired two-sample t-test for means, two-sided. Boxplots show medians and limits indicate the 25th and 75th percentiles, whiskers
extend 1.5 times the interquartile range from the 25th and 75th percentiles, outliers are represented by dots. e Upregulation of mitoribosome subunits at
the indicated time points and treatments by GSEA. f Mitochondrial components showing post-transcriptional regulation (above) are synchronized with the
downregulation of Lin28A protein (below). n = 4 independent cell lines (g) GSEA for gene sets related to translation at 14 days of treatment with 2i or
Cdk8/19i. h Protein changes of the cytosolic and mitochondrial tRNA ligases. Source data for Figs. 3a, b, d, h are provided as a Source Data file.
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dependent on Complex I and that they may have alternative
sources of ATP (Fig. 3b). Interestingly, we noticed that two
important Complex I assembly factors (Ndufaf1 and Ndufaf7)
were differentially regulated in Cdk8/19i (Supplementary Data 1),
which might cause defects in its assembly process and might
explain the results observed in our data for this inhibitor.
It has been reported that naïve cells possess immature
mitochondria and perinuclear localization28. Using transmission
electron microscopy, we confirmed such distinct features but did
not appreciate differences in the size nor the morphology of
mitochondria in 2i, Cdk8/19i cells compared to reference S/L
(Supplementary Fig. 3A). Furthermore, we used MitoTracker
staining and found similar number of mitochondria in S/L, 2i and
Cdk8/19i conditions (Supplementary Fig. 3B, C), indicating that
the upregulation of mitochondrial proteome observed in our data
responded mainly to actual changes in the protein content rather
than an increase of the mitochondrial biomass. Next, we
investigated the origin of the augmented mitochondrial proteome
in our data. Besides transcription regulation by PGC-1α29, post-
transcriptional regulation plays a role in tuning the levels of
mitochondrial proteins30,31. To test the predominant regulatory
mode in naïve pluripotency, we compared our proteome data
with matched RNA-seq3. This analysis showed an overall good
correlation between the transcriptomes and proteomes (Fig. 3c).
However, mitochondrial protein levels were significantly higher
than their mRNAs in both approaches (p.val-2i = 3E−13; p.val-
Cdk8/19i = 1E−05) (Fig. 3c, d). We did not find such
discrepancy for other organelles (Supplementary Fig. 3D). We
confirmed these findings using other RNA-seq and proteome data
sets of 2i mESCs (Supplementary Fig. 3E and Supplementary
Note 2). Notably, nearly all the subunits of the mitoribosome
peaked expression around 4–7 days, coincident with the
maximum increase of mitochondrial components (Fig. 3e). These
results indicate that the increase in mitochondrial proteins of 2i
and Cdk8/19i cells as they transition into the naïve state is
controlled, in part, post-transcriptionally.
mTOR has been linked to mitochondrial biogenesis by
promoting translation via inhibition of 4E-BPs30. Among the
targets of mTOR-enhanced translation is Tfam. However, TFAM
mRNA and protein levels remained unaltered in our data
(Supplementary Fig. 3F). On the other hand, Lin28 regulates
metabolism and transition to primed pluripotency by repressing
translation of mRNAs involved in OXPHOS31. Indeed, we found
several proteins regulated in a post-transcriptional manner that
showed opposite kinetics to Lin28 in response to both treatments.
Consistent with this, several mitochondrial proteins mirrored the
downregulation of Lin28 in a significant manner (Fig. 3f and
Supplementary Fig. 3G). In addition to OXPHOS, Lin28 binds
other mRNAs belonging to splicing factors32 and endoplasmic
reticulum33. We found 385 (2i) and 387 (Cdk8/19i) proteins (93
in common, p.val = 1.0E−19) which increased levels were not
accompanied by changes in their cognate mRNAs (Supplemen-
tary Data 3). Indeed, these genes were enriched in RNA splicing
(q.val-2i = 2.2E−17, q.val-Cdk8/19i = 4.4E−4) and the
endomembrane system (q.val-2i = 1.4E−12, q.val-Cdk8/19i =
0.006) (Supplementary Data 3). Therefore, our results seem to
agree with previous studies reporting post-transcriptional regula-
tion in mESCs through Lin28-dependent degradation31–33.
Despite above the evidence of enhanced translation, we noticed
numerous proteins involved in protein synthesis, ribosome
biogenesis, and tRNA processing that were downregulated in 2i
and Cdk8/19i (Fig. 3g). These findings may suggest that naïve
ESCs possess lower global translation rates than conventional S/L.
In fact, Myc depletion and mTOR inhibition induce a dormant
state marked by a shutdown of protein synthesis16,34. This global
reduction may balance the need of synthesis of mitochondrial
proteins (see “Discussion” section). In support of this hypothesis,
we found that, unlike cytosolic tRNA synthetases, their mitochon-
drial counterparts were predominantly upregulated (Fig. 3h).
Culture conditions define specific metabolic signatures in
mESCs. Our proteomic data suggested changes in mitochondrial
metabolism, but also in many other routes (Supplementary
Data 2). Using LC-MS/MS, we profiled the metabolomes of four
mESC lines grown for 2 weeks in S/L, 2i, or Cdk8/19i. Each cell
line was analyzed in quadruplicates. This set up led to the
quantification of 440 metabolites across all 48 samples. PCA
analysis separated samples based on culture conditions (Fig. 4a).
Differential analysis showed 184 metabolites downregulated in 2i
and 115 in Cdk8/19i (Supplementary Fig. 4A and Supplementary
Data 4). Among them, 65 were found in both inhibitors (p.val =
2E−4). In contrast, the number of upregulated compounds was
lower: 50 in 2i and 66 in Cdk8/19i, with few metabolites in
common. These results suggest that cells in 2i and Cdk8/19i
diverge partially in their metabolic state, which also differs from
reference S/L mESCs.
For instance, our data pointed out to differences in the
metabolism of amino acids and nucleotides between these two
chemical approaches. Unlike other proliferative cells, ESCs in 2i
grow in the absence of glutamine35. We found that glutamine
synthase (Glul) was actually repressed in 2i whereas it was
overexpressed in Cdk8/19i (Fig. 4b). Accordingly, glutamine and
glutamate levels differed in 2i and Cdk8/19i. Glutamine
metabolism is closely linked to asparagine and, as expected, we
observed differences in asparagine and aspartate levels as well as
in the expression of the asparagine synthetase (Asns) (Fig. 4b). Of
note, Asns is a key target of Atf4, a transcription factor that is
activated in response to amino acid imbalance36. Most of the Atf4
targets increased in 2i including proline enzymes37 (Supplemen-
tary Fig. 4B). In agreement, Atf4 and two critical effectors, Ddit3
and Eif2ak4 were only up-regulated in 2i (Supplementary Fig. 4C)
indicating that amino acid metabolism differs in this aspect
between 2i and Cdk8/19i. Furthermore, glutamine enables rapid
proliferation because of its role in multiple biosynthetic pathways
including nucleic acids. Our data revealed that mono-
phosphorylated nucleotides decreased in 2i, while the di-
phosphorylated forms increased in Cdk8/19i (Fig. 4c). Although
these metabolites can be diverted for multiple processes, we
noticed that enzymes involved in nucleotides biosynthesis (Pgls,
Gart, and Atic) were downregulated only in 2i (Supplementary
Data 1), which could explain the differences in nucleotide pools.
These findings indicate that some important aspects of nucleotide
metabolism also differ between 2i and Cdk8/19i.
Another important difference between 2i and Cdk8/19i was in
their DNA methylation levels. Despite their similarities, Cdk8/19i
cells do not phenocopy the hypomethylated genome of 2i3.
Hence, these two culture conditions might help understand the
mechanisms of DNA methylation in pluripotency. Nnmt acts as a
methyl sink in human naïve ESCs through methylation of
nicotinamide (NAM), making SAM unavailable for other
methylation reactions9. We found Nnmt mRNA expression
increased 16-fold in 2i, while it diminished in Cdk8/19i (Fig. 4d).
Consistent with these changes, our data showed low SAM levels
in 2i. Conversely, a high SAM/SAH ratio, which activates methyl-
transferases, was found in Cdk8/19i (Fig. 4d). These results
suggest that SAM availability could in part determine DNA
methylation in ESCs. In addition, DNA methylation depends on
the balance between de novo methylation, maintenance methyla-
tion, and active demethylation, and all three processes have been
implicated in the loss of methylation in 2i7,38. In our data,
Dnmt3a and Dnmt3l were among the most downregulated
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proteins in 2i, while their upstream negative regulator Prdm14
increased (Fig. 4e). Remarkably, Cdk8/19i recapitulated the same
changes (Fig. 4e). On the other hand, TET dioxygenases, Aicda
and Tdg also exhibited similar regulation (Fig. 4e). Recently,
impairment of DNA methylation maintenance was proposed as
the main cause of hypomethylation in 2i39. We found that Uhrf1
protein levels, but not its mRNA, rapidly decreased in 2i but not
in Cdk8/19i (Fig. 4e). Kdm3b, a H3K9 demethylase was also
found increased only in response to 2i. Although we cannot rule
out additional factors such as interactions, PTMs and metabolites
regulating the activity of de novo methyltransferases and active
demethylases, our data seem at least to support the model where
Uhrf1 degradation, concomitant with Kdm3b-mediated loss of
H3K9me2, impede Dnmt1 recruitment, leading to a passive loss
of 5mC in 2i39. Moreover, the high levels of SAM together with
no change in Uhrf1 protein in Cdk8/19i likely explain how Cdk8/
19i does not affect global DNA methylation levels3.
Despite the differences in the above metabolic pathways, our
data also showed that 2i and Cdk8/19i caused similar alterations
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Fig. 4 2i and Cdk8/19i impose specific metabolic signatures. a Principal component analysis of the metabolomes of mESCs grown in S/L, 2i, or Cdk8/19i.
b Glutamate, glutamine, asparagine, and aspartate levels found in S/L, 2i, and Cdk8/19i. The protein (squares) and RNA (circles) log2 ratios relative to S/L
are indicated for Glul and Asns enzymes. c Mono-phosphorylated and di-phosphorylated nucleotides levels in S/L, 2i, and Cdk8/19i. d Schematic of
methylation reactions. SAH and SAM levels measured in S/L, 2i, and Cdk8/19i culture conditions. mRNA log2 ratios of Nnmt in 2i and Cdk8/19i and
related enzymes. e Expression log2 changes of enzymes involved in DNA (de)methylation. f Schematic of the one carbon metabolism and related enzyme
levels. When available, protein (squares) and mRNA (circles) ratios are shown. In all boxplots (b–d), statistically significant changes using a moderated
t-test (limma, two-sided, FDR<5%) relative to reference S/L are indicated with an asterisk (p-value <0.05). In b–d, boxplots represent values from four
independent cell lines (with four biological replicates each) in S/L. 2i and Cdk8/19i (n = 16). Boxplots show medians and limits indicate the 25th and 75th
percentiles as determined by R software; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles, outliers are represented by
dots. Source data for figures 4a–f are provided as Source Data file.
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While serine biosynthesis proteins (Phgdh, Psat, and Psph) were
repressed in 2i and Cdk8/19i, Tdh (involved in the catabolism of
threonine into glycine) was upregulated several fold40 (Fig. 4f).
Further, choline degradation products are another important
source of 1C units. We found Bhmt, Bhmt2, and Dmgdh mRNAs
(all involved in the re-methylation of homocysteine in the liver),
were 30-fold increased in both media (Fig. 4f and Supplementary
Fig. 4D). Thus, these findings suggest that, besides threonine,
naïve ESCs may incorporate 1C units by substantially mobilizing
choline. Interestingly, both sources converge into 5,10-meTHF
which is essential to produce the taurinomethyluridine base of
mitochondrial tRNAs41 (see “Discussion” section).
Naïve cells upregulate proteins involved in fatty acids beta-
oxidation. Hif1a promotes a glycolytic metabolism in EpiSCs6.
Cdk8 kinase activity is required for induction of many Hif1a
targets and supports glycolysis in cancer cells42,43. In concordance,
our proteome data showed multiple Hif1a targets involved in
glycolysis were downregulated by both 2i and Cdk8/19i (Fig. 5a).
Moreover, several glycolytic metabolites were reduced in 2i or
Cdk8/19i (Fig. 5a and Supplementary Data 4). Furthermore, we
found that both inhibitors increased most of the TCA cycle and
ETC enzymes (Fig. 5b). TCA intermediates however showed little
changes. Together, these results suggest that naïve cells may re-
balance the bivalent metabolism by enhancing mitochondrial
respiration while diminishing glycolysis.
The major change in our metabolomic data involved the lipid
content. 36% (2i) and 42% (Cdk8/19i) of the downregulated
metabolites belonged to lipid metabolism. Importantly, 30 of
them decreased in both inhibitors (p.val = 3E−15) indicating that
both drugs induced a similar lipidomic signature (Fig. 5c).
Interestingly, 50% of the upregulated metabolites in 2i were also
lipids, including glycerophospholipids and sphingomyelins (Sup-
plementary Data 4). Lipid metabolism is emerging as an
important player in pluripotency but studies have reported
diverging results on the role of fatty acid oxidation9 and de novo
lipogenesis44. Here, the overall decrease in lipids found in 2i and
Cdk8/19i suggests high beta-oxidation levels and/or reduced lipid
synthesis. We found that lipid catabolism and beta-oxidation
pathways including Cpt1a and Slc25a20 from the carnitine
transport system were upregulated (Fig. 5d, e). Peroxisomal
enzymes like Acox3 and Decr2 also increased, indicative of
oxidation of very long fatty acids as well (Fig. 5d). Furthermore,
during mouse development, the expression of beta-oxidation
enzymes is highest in the ICM and pre-implantation45 and their
protein levels are rapidly down-regulated as cell transit to primed
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Fig. 5 Naïve cells possess an enhanced oxidative phosphorylation and beta-oxidation. a Schematic of glycolysis reactions and related enzyme levels
(relative to S/L) in 2i and Cdk8/19i. Protein (squares) and mRNA (circles) log2 ratios are shown. Hif1a targets as described by Galbraith et al.42 are
underlined. Below, glycolytic metabolites found altered in 2i or Cdk8/19i (relative S/L) using a moderated t-test (limma, two-sided, FDR<5%) are indicated
with an asterisk (p-value <0.05). b Upregulation of proteins related to TCA and ETC at 14 days of treatment with 2i or Cdk8/19i shown by GSEA analysis.
c Overlap between the lipids down-regulated in 2i and Cdk8/19i conditions (relative to S/L). Some examples of down-regulated lipids are shown below.
d Log2 ratios of key enzymes involved in the carnitine transport system, peroxisomal oxidation of lipids and fatty acid synthesis. e GSEA shows the
upregulation of fatty acid beta-oxidation proteins at 14 days of treatment with 2i or Cdk8/19i. In a and c, boxplots represent values from four independent
cell lines (with four biological replicates each) in S/L, 2i and Cdk8/19i (n = 16). Boxplot show medians and limits indicate the 25th and 75th percentiles as
determined by R software; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles, outliers are represented by dots. Source
data for Figs. 5a, c and d are provided as Source Data file.
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upregulated (Fig. 5D), we did not find any GO term that would
support increased lipid biosynthesis (Supplementary Data 2).
Collectively, these results might imply that mitochondria in the
naïve state are metabolically active and characterized by high
levels of beta-oxidation.
Phosphoproteomics confirms the selectivity of Mek/Gsk3i and
Cdk8/19i. The similar proteomic and metabolomic changes of 2i
and Cdk8/19i prompted us to investigate the immediate effects of
these drugs using phosphoproteomics. Four S/L mESC lines were
supplemented with 2i or Cdk8/19i and collected after 0.5, 1, 2,
and 6 h (Fig. 1a, Supplementary Fig. 5A, and Supplementary Note
3). Samples were distributed across four TMT-11plexes, and
purified phosphopeptides were analyzed by LC-MS/MS, enabling
the quantification of 14,276 p-sites in all 44 conditions (Supple-
mentary Fig. 5B). PCA revealed a clear separation of 2i and Cdk8/
19i phosphoproteomes from S/L, indicating a profound alteration
in the phosphorylation landscape of mESCs immediately upon
addition of these kinase inhibitors (Fig. 6a). 4261 and 5732 p-sites
were significantly regulated after 0.5 h of 2i or Cdk8/19i respec-
tively (Fig. 6b and Supplementary Data 5). Strikingly, 40% of
these changes were common to both inhibitors. Similar overlaps
were found at 1, 2, and 6 h (Fig. 6b). Clustering classified p-sites
into 14 temporal profiles including six clusters exhibiting alike
kinetics in both inhibitors (Fig. 6c and Supplementary Fig. 5C).
These results suggested that 2i and Cdk8/19i re-wired phos-
phorylation networks in a similar manner. Next, we examined the
status of the 43 phosphatases and 137 kinases identified in our
data, and found that several of them displayed comparable
phosphorylation regulation in 2i and Cdk8/19i, which could
explain the partial convergence in their phosphoproteomes. For
instance, S1261-T1262 from mTOR were heavily downregulated,
suggesting decreased kinase activity46 (Fig. 6d and Supplementary
Fig. 5D). Consequently, Ulk1 showed dephosphorylation of sev-
eral residues including S637 (mTOR site), an event that promotes
an acute autophagy induction47. Furthermore, our data showed
inhibition of kinases involved in protein synthesis such as S6K
(S394, mTOR site) and Eef2k (T347, S6K site) (Fig. 6d and
Supplementary Fig. 5D). In addition, 2i and Cdk8/19i-induced
phospho-changes showed widespread effects on nuclear functions
(Supplementary Fig. 6 and Supplementary Data 6). For instance,
we found cell cycle proteins similarly regulated in both inhibitors
(cluster #2, q.val = 4E−11). This included hypo-phosphorylated
RB that, together with the increased expression of p21/p27,
confirmed the elongated G1 phase typical of naïve ESCs48.
Interestingly, our data also suggested that naïve cells are partially
relieved from the G2/M checkpoint through inhibition of Chek1:
phosphorylation of its catalytic site (S317) significantly dimin-
ished, and its motif was enriched among the downregulated
p-sites (q.val=1.6E−10) (Supplementary Fig. 7 and Supplemen-
tary Data 7), which included known Chek1 targets.
Despite the above similarities, we noted some important
differences in the phosphoproteome response to Cdk8/19i and 2i.
The two most differential p-sites between 2i and Cdk8/19i
belonged to Mek (Fig. 6f). The PD0325901 structure does not
disrupt the phosphorylation of the Mek activation loop, which
was consequently relieved from the negative feedback of the
pathway, resulting in the accumulation of phosphorylated Mek in
S222/S22649 (Fig. 6g). As expected, Mek inhibition reduced Erk
phosphorylation at Y185 of the TEY motif (Fig. 6g). Likewise, we
found several changes in p-sites of Raf proteins, altogether
confirming the potent inhibition of the Fgf/Mek/Erk pathway,
within the first 6 h of exposure to the PD0325901 inhibitor.
Meanwhile, the Gsk3 inhibitor, CHIR99021, led to progressive
stabilization of beta-catenin protein levels and, consequently,
upregulation of Axin2 and Cdx150 (Supplementary Data 9).
Cdk8 kinase activity is less understood and its effects are cell
context dependent. Among the few substrates known for Cdk8 is
histone H351, which showed decreased phosphorylation in S29 in
Cdk8/19i. Recently, Poss et al.52 identified 64 putative Cdk8/19
phospho-targets in human cancer cells using a different Cdk8/19
inhibitor, cortistatin A52. Despite several significant experimental
differences between both data sets, we identified 13 of those
substrates in our data, of which, five showed diminished
phosphorylation in response to Cdk8/19i (Supplementary Data 5).
Of note, these proteins were tightly linked to transcription,
including the regulatory subunit of the kinase module Med13l,
Brd9, Nab2, Znf609, and Huwe1.
To understand the differential response of 2i and Cdk8/19i, we
focused on Gsk3. Since Gsk3 is a constitutively active kinase
targeting S/T at four residues upstream of a pre-phosphorylated
priming site, we checked in our data for doubly-phosphorylated
peptides bearing such motif. Indeed, this Gsk3 motif was highly
enriched among the phosphopeptides decreasing in 2i (cluster #6,
p.val = 9.37E−18), and almost half of those peptides were co-
phosphorylated in the priming site (Supplementary Fig. 7 and
Supplementary Data 8). Due to diminished Gsk3 activity in 2i, we
reasoned that the priming mono-phosphorylated peptide could
remain unaltered or even increase, providing further evidence of
its identity as a Gsk3 substrate and reveal information on its
stoichiometry. For instance, the di-phosphorylated T58-S62
peptide of Myc decreased in 2i, with a concomitant increase of
the priming mono-phosphorylated S62 (Fig. 6h). Notably, our
data identified multiple potential Gsk3 targets including S324/
T328 in Ezh2 (Supplementary Fig. 8). Interestingly, Gsk3 has
been reported in cancer cells to phosphorylate these Ezh2
residues in the cytosol53 and mounting evidence shows that
cytosolic Ezh2 has non-canonical roles through methylation of
non-histone proteins54. Thus, despite the known role of Ezh2 in
the naïve state as part of the PRC2 complex by protecting 2i-ESCs
from primed-like features14, our data suggest that Ezh2 might
also have additional functions in a PRC2-independent manner.
An interplay of downstream transcriptional effectors are
regulated in 2i. Among the proteins showing the highest dif-
ferences in phosphorylation between 2i and Cdk8/19i we found
Erf (Supplementary Fig. 9A). Erf is a direct sensor of Erk activity,
with links to pluripotency55. Our data shows that in 2i, Mek-Erk
signaling inhibition leads to rapid dephosphorylation of Erf at
S20/21 (Fig. 7a and Supplementary Fig. 9B), which, as corro-
borated by immunofluorescence, facilitates its stabilization and
nuclear translocation55–57 (Fig. 7b). In contrast, Cdk8/19i did
not produce any effect on Erf phosphorylation, nor changes in its
localization (Fig. 7a, b and Supplementary Fig. 9B), indicating
that Cdk8/19i had no impact on this ERK downstream target.
Nuclear Erf is mainly a transcriptional repressor but it can also
activate gene expression55. To assess the contribution of Erf in
naïve pluripotency, we mapped Erf targets, as reported by
Mayor-Ruiz et al.55, in our data. Genes where Erf has been
shown to act as a repressor were downregulated only in 2i,
whereas those where Erf acts as a transactivator were pre-
dominantly increased (Fig. 7c and Supplementary Fig. 9D).
These transcriptional changes occurred within 24 h of 2i, sug-
gesting that Erf might be an early downstream effector of 2i.
Among the Erf-repressed genes as reported in Mayor-Ruiz
et al.55, there are negative regulators of the Erk pathway (q.val =
5E−3) including DUSPs and SPRYs but also genes from the
primed state such as Otx2, Utf1, Sox3, Lin28b, and Lef131,58,59 all
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of which were downregulated in 2i (Fig. 7d). Furthermore, Erf-
repressed genes tend to exhibit promoter proximal pausing of
RNAPII (p.val = 2E−22) and overlapped with those activated
by Zic3 (p.val = 1E−22), which promotes the transition to
primed pluripotency60 (Supplementary Fig. 9C), highlighting the
potential role of Erf as a repressor in maintenance of the naïve
state. On the other hand, among the genes where Erf is reported
to increase transcription55, there are key naïve pluripotency
factors including Prdm4 and Tbx3 that were upregulated in 2i
(Fig. 7d). Similarly, we found up-regulation of other critical
targets of pluripotency from the LIF-STAT3, Wnt and BMP4-
SMAD signaling pathways (Fig. 7d).
30min 2049 2660 1404 3.7 0
1h 1423 1299 768 5.9 0
2h 1514 1955 969 4.7 0
6h 2574 2790 1669 3.3 0
30min 2212 3072 1458 3.1 0
1h 1329 740 5.3 0
2h 1800 2037 969 3.8 0
6h 2966 2999 1730 2.8 0
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UP 2i UP Cdk8/19i Common RF p.value
DOWN 2i
DOWN







































































































































phospho-regulation Serum/LIF + 2i (MEK/GSK3)
2i vs SL     
Cdk8/19i vs SL






















0.5h 1h 2h 6h
Rps6kb1-S394


































































































Fig. 6 Time-resolved phospho-proteomics in response to 2i or Cdk8/19i. a Principal component analysis of the phospho-proteomes of cells treated with
2i or Cdk8/19i at different time points. b Differentially regulated p-sites using a moderated t-test (limma, two-sided, FDR < 5%) at the indicated time
points. The number of common p-sites between 2i and Cdk8/19i is shown together with the corresponding p.values calculated with a hypergeometric test
(RF indicates “Representation factor”). c Gap statistics and K-means classified the regulated phospho-proteome into 14 different clusters. Centroids are
indicated with a thick red (2i) or blue (Cdk8/19i) line. Only six clusters are shown in the figure. The other 8 clusters are shown in Supplementary Fig. 5C.
Color gradient in line plots indicates proximity to the centroid of the cluster. d Changes in p-sites of kinases involved in mTOR signaling in 2i or Cdk8/19i
(n= 4 independent cell lines). Statistically significant changes using a moderated t-test (FDR < 5%) relative to reference S/L are indicated with an asterisk
(p-value < 0.05). e Changes in phosphorylation of S317 regulatory site of Chek1 as well as two known Chek1 substrates (n= 4 independent cell lines).
Statistically significant changes using a moderated t-test (FDR < 5%) relative to reference S/L are indicated with an asterisk (p-value < 0.05). f Ranked p-
sites by their absolute difference between 2i and Cdk8/19i. Mek2 p-sites identified in our dataset are indicated. g Phosphorylation changes of Mek/Erk
regulatory sites. Points indicate the average of n = 4 independent cell lines. Statistically significant changes using a moderated t-test (FDR < 5%) relative to
reference S/L are indicated with an asterisk (p-value < 0.05). h Schematic model of Myc phospho-regulation in S/L and 2i. Changes in the T58/S62 di-
phosphorylated Myc peptide and the S62 monophosphorylated are shown (n= 4 independent cell lines). Statistically significant changes using a
moderated t-test (FDR < 5%) relative to reference S/L are indicated with an asterisk (p-value < 0.05). Source data for Fig. 6a are provided as Source
Data file.
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Our phosphoproteomic data uncovered capicua (Cic) as
another transcriptional target that was rapidly dephosphorylated
only in 2i (Fig. 7a and Supplementary Fig. 9A, B). Similar to Erf, 2i
impedes Erk-mediated nuclear export and/or degradation of Cic,
leading to its nuclear accumulation and activation61. In agreement
with its role as a repressor, we found that several Cic targets, as
reported by Weissmann et al61, were repressed in 2i. These include
formative pluripotency genes58, ERK negative regulators as well as
AP-1 factors (Fig. 7c, d). Moreover, we also identified Cic as a
potential substrate of Gsk3 (Supplementary Data 8), suggesting
that both Mek-Erk and Gsk3 pathways might have synergistic
downstream effects. Altogether, these data suggest that in 2i, ERKi,
and GSK3i converge in the stabilization of downstream factors
that, probably in cooperation with other proteins, participate
in: (i) repressing the transcriptional programs of development; (ii)
ensuring the shutdown of the Erk pathway; and (iii) reinforcing
the naïve circuitry.
Activation of super-enhancer-associated genes key for plur-
ipotency in Cdk8/19i. Unlike 2i, inhibition of Cdk8/19 did not
regulate the above transcriptional factors but recapitulated much
of the expression program of 2i. To understand the mechanism of
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Fig. 7 Phosphoproteomics identifies downstream proteins that stabilize the transcriptional naïve circuitry in 2i and Cdk8/19i. a 2i but not Cdk8/19i
reduces phosphorylation levels of Erf and Cic (n = 4 independent cell lines). Statistically significant changes using a moderated t-test (FDR < 5%) relative
to reference S/L are indicated with an asterisk (p-value < 0.05). b Immunofluorescence analysis of ERF subcellular localization in mESCs in S/L o 2i or
Cdk8/19i. Experiment was performed in duplicates. c GSEA results using gene sets extracted from the indicated sources. d Transcription factors and
components of signaling pathways involved in pluripotency, indicating whether they are regulated by Erf (Mayor-Ruiz et al.55), Cic (Weissmann et al.61)
and/or controlled by super-enhancers (Whyte et al.68). The mRNA log2 ratios are shown for Cdk8/19i and 2i (additional 2i data sets are also shown).
e Phosphorylation levels (n= 4 independent cell lines) of several Cdk8/19 targets in response to 2i or Cdk8/19i. Statistically significant changes using a
moderated t-test (FDR<5%) relative to reference S/L are indicated with an asterisk (p-value < 0.05).
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of this inhibitor but unaffected or with opposite kinetics in 2i
(Supplementary Data 5). For instance, Mcm3, Claspn, and Ticrr
were regulated by phosphorylation in response to Cdk8/19i,
supporting a recent report that links Cdk8 with DNA
replication62. In addition, we found Cdk8/19i-specific changes in
Aebp2 and Jarid2 suggesting that Cdk8 may also regulate PRC263.
The implication of Cdk8 on epigenetics in our data was further
evidenced by dephosphorylation of Dnmt3l64. However, given the
main role of Cdk8 in transcription, we focused on proteins
involved in this process. We found dephosphorylation in Aff1
and Aff4 from the super elongation complex in Cdk8/19i but not
in 2i. Moreover, Ccnt2, the cyclin of the pTEFb, and Cdk13,
involved in CTD phosphorylation and elongation, were also
regulated only in Cdk8/19i (Fig. 7e). Therefore, these results
indicate that Cdk8/19i may elicit part of its effects through pro-
teins involved in the productive elongation phase of RNPII.
Although Cdk8 can activate gene expression42,65, it is mostly
known for its repressive effect on transcription as a negative
regulator of mediator66. Remarkably, Cdk8/19 inhibition with
cortistatin A has been shown to activate genes that are under
control of super-enhancers (SE) in AML67. To test whether a
similar mechanism plays a role in the stabilization of naïve
pluripotency by our Cdk8/19 inhibitor, we checked Cdk8/19i-
dependent expression of genes that are transcriptionally-regulated
by SE in S/L mESCs68. Indeed, we found that Cdk8/19i, but not
2i, showed a positive co-regulation of protein and RNA levels of
SE-genes (Fig. 7c and Supplementary Fig 9D). Importantly, this
effect was evident by day 1 of Cdk8/19i exposure. Among the SE-
genes upregulated by Cdk8/19i there were naïve pluripotency
factors including Tbx3, Klf2 Esrrb, Prdm14, and Tcfcp2l1
(Fig. 7d). Other SE-genes that showed significant expression
included metabolic enzymes and cell surface molecules. Never-
theless, among the genes under control of SEs there were also
transcription factors associated to formative and primed states
that were consequently upregulated, including Otx2, Utf1, Rbpj,
Pum1, and Tcf15 (Fig. 7d). Of note, most of these factors have
been reported to be repressed by Erf and Cic55,61 and were
downregulated in 2i. Similar regulation was found for other SE
genes such as SPRYs, Epha2, and Smarcd1 that were found
repressed in 2i while activated in Cdk8/19i. Together, our results
suggest a model in which Cdk8/19i regulate, among others,
proteins involved in transcriptional processes such as elongation,
probably leading to de-repression of SE-driven expression of key
identity genes. These include components of the naïve tran-
scriptional circuitry but also some factors from primed and for-
mative pluripotency.
Discussion
To better understand the regulatory principles underpinning the
establishment of naïve pluripotency, we used MS to characterize
two chemical approaches that target extracellular signaling (2i)
and transcriptional machineries (Cdk8/19i). We propose a model
in which 2i and Cdk8/19i result in a similar activation of naïve
genes through different mechanisms. Although more factors
might be involved, we showed that Erk inhibition results in the
rapid activation of Cic and Erf (Fig. 8). The integration of our
phosphoproteomic and transcriptomic data with published ChIP-
seq data suggest that these downstream effectors might partici-
pate in the transcriptional response that activates the naïve pro-
gram, while repressing the more developmentally advanced
primed and formative states. Alternatively, a similar outcome is
achieved by stimulation of key stem cell genes under the control
of super-enhancers. Inhibition of Cdk8/19, a repressor of the
Mediator complex, regulates proteins involved in processive
transcription elongation. In Cdk8/19i, naïve but also some
primed and formative genes are activated (Fig. 8). Yet, mESCs
grown in Cdk8/19i functionally resemble the 2i state3 demon-
strating the robustness of the self-organizing naïve network to
destabilizing cues.
Once activated, the naïve circuitry entails the execution of a
complex sequence of molecular events. We found that a feature of
the naïve state is the upregulation of mitochondrial proteins,
which seems to be partially controlled post-transcriptionally.
Interestingly, these results contrast with a recent report that
found that proteomic changes in the naïve state are largely driven
by transcriptomic rewiring, with little contribution of other reg-
ulatory layers12. We have now re-examined these results and
found evidences of post-transcriptional regulation in their data
too (Supplementary Note 2). Genes regulated mainly at the
translational level in Atlasi et al12. (RNA < RFP) were enriched in
endoplasmic reticulum and plasma membrane (FDR = 0) but not
in mitochondria. However, we found that mitochondrial proteins
were indeed more upregulated at the protein than the mRNA
(p.val = 1.2e−38) or RFP (p.val = 1.9e−31) levels. Moreover, in
agreement with our results, divergences in mRNA-protein in
Atlasi’s data were coincident with the downregulation of Lin28,
underscoring the known role of this RNAbp in post-
transcriptional repression in mESCs12. Given that RFP is a
direct reflection of translational activity, it is intriguing that the
upregulation of mitochondrial protein levels (MS) was not
detected in the RFP data. Multiple explanations may account for
such discrepancy including differences in bulk vs. local RFP
measurements and stalled/paused polysomes (Supplementary
Note 2).
Interestingly, the upregulation of mitochondrial proteins may
be facilitated by two additional events. Firstly, in line with prior
reports69–71, we found that either 2i or Cdk8/19i lead to de-
phosphorylation of mTOR, possibly affecting catabolism/anabo-
lism rates. It is well established that protein synthesis is repressed
under stress conditions, where the translation machinery is
diverted to selectively promote stress-response proteins72. A
similar translational reprogramming might occur here: the sub-
stantial demand for translation of mitochondrial proteins to
transition to the naïve state could be counterbalanced by tuning
down global protein synthesis, as well as the recycling of cellular
components through autophagy. Secondly, the over-expression of
several enzymes that feed 1C units suggests that naïve cells may
adapt their one carbon metabolism to cope with mitochondrial
translation rates. Although this would require further examina-
tion of one-carbon fluxes by means of stable isotope tracers.
Interestingly, both threonine and choline sources converge into
5,10-meTHF which is essential to produce the taurinomethylur-
idine base of mitochondrial tRNAs41. Therefore, it is our
hypothesis that naïve ESCs might increase 5,10-meTHF levels to
meet the demand of methylated mitochondrial-tRNAs needed for
maintaining the high translation rates of mitochondrially-
encoded proteins. Of note, these enzymes are repressed as cells
progress to primed pluripotency10, and they exhibit specific
expression in the morula and ICM2, further supporting their roles
in pluripotency.
Despite their similarities, 2i and Cdk8/19i showed differences
in several metabolic pathways. The upregulation of Nnmt in 2i
diverts SAM from methylation reactions9. In contrast, Nnmt
levels remain basal in Cdk8/19i, consistent with their lack of
hypomethylation3. Another contributing factor could be the 2i-
dependent degradation of Uhrf1 that impedes the recruitment of
Dnmt1 leading to a passive loss of methylated bases during
replication39. Although low levels of DNA methylation are con-
sidered a hallmark of naïve pluripotency given its resemblance
with the demethylation wave of the ICM, it has been reported that
prolonged culture in 2i can have deleterious effects on the
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chromosome integrity of mESCs8. In this scenario, Cdk8/19i
would be an attractive alternative, as these cells exhibit similar
functional capacities to 2i, while methylation is stable and not
subject to progressive loss3.
In our previous work, we have shown that Cdk8/19i also shifts
human ESCs towards the naïve state3, hence, some of the events
described here might play a role in this system too. Moreover, our
data might be valuable in other areas such as cancer. Inhibition of
Cdk8 reduces cell proliferation in AML through activation of
tumor suppressors67. In colorectal cancer cells however, Cdk8
acts as an oncogene43. Here, we show that Cdk8/19i leads to
phosphorylation changes in hundreds of proteins, which may
help in understanding the context-dependent functions of these
kinases. While the primary function of Cdk8/19 resides in the
nucleus, and potential off-targets cannot be neglected, Cdk8/19
can indeed function independent of core Mediator51 and it has
been recently found in the cytoplasm73, suggesting that the target
spectrum of these kinases may be larger than anticipated. On the
other hand, the Erk pathway involves multistep reactions and
feedback loops, that generate various behaviors. The PD0325901
used in 2i, and many other Mek inhibitors, do not disrupt the
phosphorylation of the Mek1/2 activation loop, which can explain
the rebound in phosphorylated Erk1/2 and pathway output that is
observed with this type of inhibitors, notably in Ras-driven
cancers. Indeed, one of the downstream effectors identified here,
Cic, has been shown to modulate sensitivity to Mek-inhibitors74.
Thus, our data might be used to identify potential vulnerabilities
and resistance mechanisms to such compounds.
Methods
More detailed descriptions of the methods employed in the current study is
included as Supplementary Methods in the supplementary information.
Mouse cells and culture conditions. The experimental design consisted of four
different mouse embryonic stem cell lines: TNGA, TON, ZS and BL6. Wild-type ES
cells were derived at the Transgenic Mouse Unit of CNIO from E3.5 C57BL6
blastocysts (BL6), or mixed background C57BL6/129 (V6.4) blastocysts. Nanog-
GFP knock-in mouse ES cells (TNGA, TON) and were shared by the laboratory of
Austin Smith; The ZS mouse ES line was a 2C-reporter shared by the laboratory of
Minoru Ko. Mouse ES cells were routinely cultured on gelatin-coated plates in a
base media of “Serum/LIF” (15% FBS), in DMEM (high glucose) basal media, with
LIF (1000 Units/ml), non-essential amino acids, glutamax and β-mercaptoethanol
plus antibiotics. Where used with mouse PSC, the “2i” two-inhibitor cocktail
comprised 1 μM Mek-inhibitor (PD0325901, Axon Medchem, #1408) plus 3 μM
GSK3β-inhibitor (CHIR 99021, Axon Medchem #1386). The Cdk8/19i was sup-
plemented at 1.1 μM. Cultures were routinely tested for mycoplasma. Cell pellets
were collected by trypsinization at different time points after treatment with 2i or
Cdk8/19i: 30 min, 1, 2, and 6 h, 1, 2, 4, 7, 10 and 14 days of treatment and washed
with PBS and preserved at −80 °C for further analysis.
Sample processing and LC-MSMS analysis for proteomics. Four mouse
embryonic stem cell lines were used: TNGA, TON, ZS, and BL6. Each cell line was
employed as a biological replicate, so the overall experiment consisted in four
biological replicates. For time course full proteome analysis cells were lysed using 7
M urea, 2 M thiourea, 50 mM Hepes, 1:1000 (v/v) of benzonase and 1:100 (v/v) of
HaltTM phosphatase and protease inhibitor cocktail 100×. Cell lysates were
Fig. 8 Working model for 2i and Cdk8/19i -mediated mechanisms involved in the stabilization of naïve pluripotency. 2i-dependent inhibition of Mek/
Erk prevents phosphorylation of Erf and Cic, stabilizing both factors in the nucleus. These transcriptional effectors might participate in the activation of
genes involved in naïve pluripotency whereas they repress factors involved in primed/formative states. Cdk8/19i affects the phosphorylation of proteins
involved in elongation and transcription machineries such as super elongation complex (SEC), RNA pol II (RNPII) and Mediator (MED). This might lead to
rapid activation of genes controlled by super-enhancers. These genes include factors that stabilize the naïve state but also some factors from the primed/
formative states which are also upregulated in response to Cdk8/19i. Upon activation of the naïve circuitry in 2i and Cdk8/19i, several events might support
the enhanced mitochondrial OXPHOS capacity of these cells. Degradation of Lin28a might relieve target mRNAs from its repression effects and, among
others, mitochondrial proteins become upregulated. The balance of autophagy and protein synthesis may sustain the translation of such mitochondrial
components. In addition, re-wiring of mitochondrial sources for one carbon units may also sustain the translation of mitochondrial-encoded proteins. On
the other hand, the availability of SAM levels (by NNMT upregulation) together with the impairment of DNA methylation (by Uhrf1 degradation) contribute
to the hypomethylated DNA typical of 2i.
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homogenized by sonication and cleared by centrifugation. Protein concentration
was measured with Qubit® Protein Assay Kit. One hundred and ten microgram of
each lysate (except for control conditions for which 220 µg were used) were
digested using the filter aided sample preparation (FASP) method. A first digestion
using Lys-C (1:50 w/w, Wako Pure Chemical Industries) for 4 h was followed by a
dilution 8-fold in 50 mM TEAB and a subsequent digestion with trypsin (1:100
w/w, Promega) overnight at 37 °C. Labeling was performed using the iTRAQ®
Reagent 8plex kit (AB Sciex). Labeled samples were combined and cleaned-up with
C18 Sep-Pack. Eluate was dried and dissolved in 10 mM of NH4OH for subsequent
fractionation by high pH reversed phase chromatography. Collected fractions were
dried and dissolved in 50 µl of 1% FA for LC-MS/MS analysis. The Impact (Bruker
Daltonics) was coupled online to a nanoLC Ultra system (Eksigent). 7.5 µl of each
fraction were loaded onto a reversed-phase C18, 5 µm, 0.1 × 20 mm trapping
column (NanoSeparations) and washed for 15 min at 2.5 µl/min with 0.1% FA. The
peptides were eluted at a flow rate of 250 nl/min onto a home-made analytical
column packed with ReproSil-Pur C18-AQ beads, 1.9 μm, 75 μm × 50 cm, heated
to 45 °C. Solvent A was 4% ACN in 0.1% FA and Solvent B CH3CN in 0.1% FA.
The MS acquisition time used for each sample was 180 min. The Q-q-TOF Impact
was operated in a data dependent mode. The 20 most abundant isotope patterns
exceeding a threshold of 5000 counts and with charge ≥2 and m/z > 350 from the
survey scan were sequentially isolated and fragmented in the collision cell by
collision induced dissociation (CID).
For time course phosphoprotome profiling cells were lysed using 5% SDS and
digested following the S-trap protocol. Samples were labeled using TMT11plex
reagent following manufacturer instructions. Labeling reaction was stopped by
addition of 1% hydroxylamine; then samples were combined and desalted using
C18 Sep-Pack. To perform phosphopeptide enrichment, peptides were dissolved in
80% CH3CN and 6% TFA. Titanium dioxide (TiO2) beads were prepared at 60 µg
beads/µl of DHB solution (20 mg/ml DHB in 80% CH3CN 6% TFA). TiO2 beads
were added to the sample in a ratio 1:2 (Sample:TiO2) and incubated for
15 minutes. Supernatant was used for a second binding with half the amount of
beads. Beads from the first and second TiO2 binding were transfer to separate C8-
tips and washed. Peptides were eluted with 25 µl of 5% NH4OH and 25 µl of 10%
NH4OH 25% CH3CN. Eluate from the second TiO2 binding was resuspended in
22 µl 5% FA for LC-MS/MS analysis. Eluate from the first binding was fractionated
with high pH reverse phase microcolumns. Sample was loaded into the tips thrice
and the flow-through was collected to a vial. Next, 50 µl of phase A (20 mM
NH4OH) was loaded and collected as the flow-through. Peptides were sequentially
eluted increasing the percentage of Buffer B (20 mM NH3 in CH3CN). Samples
were dissolved in 22 µl of 5% FA for subsequent LC-MS/MS analysis. Three
replicates were run for each sample. The experiments were performed on an
Ultimate 3000 RSL nano LC system (Thermo Scientific) coupled to a Q Exactive
HF-X mass spectrometer (Thermo Scientific) equipped with an EASY-spray ion
source (Thermo Scientific). The peptides were eluted from an Easy-Spray Column
(75 µm i.d. × 50 cm) packed with PepMap RSLC C18 2 µm by application of a
binary gradient consisting of 0.1% FA (buffer A) and 100% ACN in 0.1% FA
(buffer B), with a flow rate of 250 nl/min during 90 min. The column was operated
at a constant temperature of 45 °C. The MS survey was performed in the Orbitrap
for a m/z range between 350 and 1500 m/z. The resolution was set to 60,000
FWHM at m/z 200. The 15 most abundant isotope patterns with charge ≥2 and <6
from the survey scan were selected with an isolation window of 1 m/z and
fragmented in the HCD collision cell. Normalized collision energy was set to 35.
The resulting fragments were detected in the Orbitrap for a m/z range between 100
and 2000 m/z with a resolution of 45,000 FWHM at m/z 200. The maximum ion
injection times for the survey scan and the MS/MS scans were 45 ms and 80 ms,
respectively and the ion target values were set to 3e6 and 5e4, respectively for each
scan mode. Raw data was acquired using Xcalibur (Q-Exactive software Tune
version 2.9, Thermo).
Proteomics raw data processing and statistical analysis. Proteome raw files
were analyzed using MaxQuant 1.5.3.30 and 1.6.0.16 for full proteome and
phosphoproteome datasets, respectively, against a Mus musculus database (Uni-
ProtKB/Swiss-Prot, 43,539 sequences). For total proteome sample quantification
type was set to iTRAQ8plex, whilst for phospho-proteome it was set to
TMT11plex. Carbamidomethylation of cysteine was included as fixed modification
and oxidation of methionine and acetylation of protein N-terminal were included
as variable modifications. Phosphorylation of serine, threonine, and tyrosine was
also included as variable modification in the phosphoproteomics dataset. Peptides
and proteins were filtered at 1% FDR. For protein assessment (FDR < 1%) in
MaxQuant, at least one unique peptide was required for identification. Only unique
peptides were used for protein quantification. Reverse, only identified by site and
proteins or phospho-sites that did not have reporter intensity in all channels were
discarded for further analysis. Reporter intensities for the full proteome time course
were extracted from “proteingroups.txt” table, and the reporter intensities for the
phosphorylation sites were extracted from “Phospho(STY)Sites.txt” table. Data was
further processed using R and Perseus. Reporter intensities were transformed to
log2 and normalized within each experiment using “normalizecyclicloess” function
from limma package in R. In order to integrate the independent experiments a
further interexperiment normalization was conducted using ComBat function from
sva package in R.Statistical determination of differential proteins, and phosphor-
ylation sites at each time point versus Serum/LIF initial conditions was performed
using a two-sided limma approach implemented in Prostar (version 1.12.4). We set
a minimum fold change of 0.1 (log2) and a maximum p-value for each condition.
The p-value threshold was adjusted by Benjamini–Hochberg correction to a
5% FDR.
Sample processing and LC-MSMS analysis for metabolomics. Four mouse
embryonic stem cell lines were used: TNGA, V6.4, ZS, and BL6. Metabolomic
profiling was performed in collaboration with Metabolon Inc. Samples were pre-
pared using the automated MicroLab STAR® system from Hamilton Company.
Several recovery standards were added prior to the first step in the extraction
process for QC purposes. To remove protein, dissociate small molecules bound to
protein or trapped in the precipitated protein matrix, and to recover chemically
diverse metabolites, proteins were precipitated with methanol under vigorous
shaking for 2 min (Glen Mills GenoGrinder 2000) followed by centrifugation. The
resulting extract was divided into five fractions: two for analysis by two separate
reverse phase (RP)/UPLC-MS/MS methods with positive ion mode electrospray
ionization (ESI), one for analysis by RP/UPLC-MS/MS with negative ion mode ESI,
one for analysis by HILIC/UPLC-MS/MS with negative ion mode ESI, and one
sample was reserved for backup. Samples were placed briefly on a TurboVap®
(Zymark) to remove the organic solvent.
Metabolite quantification, data normalization and statistical analysis. Raw
data was extracted, peak-identified, and QC processed using Metabolon’s hardware
and software. Compounds were identified by comparison to library entries of
purified standards or recurrent unknown entities. Metabolon maintains a library
based on authenticated standards that contains the retention time/index (RI), mass
to charge ratio (m/z), and chromatographic data (including MS/MS spectral data)
on all molecules present in the library. Furthermore, biochemical identifications are
based on three criteria: retention index within a narrow RI window of the proposed
identification, accurate mass match to the library +/− 10 ppm, and the MS/MS
forward and reverse scores between the experimental data and authentic standards.
The MS/MS scores are based on a comparison of the ions present in the experi-
mental spectrum to the ions present in the library spectrum. Peaks were quantified
using area-under-the-curve. To account for differences in metabolite levels due to
differences in the amount of material present in each sample, we have applied an
additional normalization factor based on the total protein as determined by
Bradford assay. One of the samples was discarded in this step due to the high
presence of missing values (cell line V6.4, treatment 2i, and replicate 2). After-
wards, data processing was performed within Prostar R package (version 1.12.16).
Metabolites that were not quantified in at least 75% of the samples in one treatment
were discarded. Data was transformed to log2 scale and missing values were
imputed using Imp4p for values missing at random, and with LAPALA with upper
bound 2.5 for values missing in an entire condition. Once missing values were
imputed, data was normalized by quantile centering to the median. Finally, with
these data we performed differential analysis using limma (v3.36.1) with a design
that account for biological replicates of the same cell line, with p-value correction of
5% FDR.
Z-scoring, temporal trend classification, and boxplot representation. Z-score
or mean-centering normalization was applied to normalize protein and phos-
phosite intensities. Z-score was applied after collapsing all replicates to their
average at each time point. Next, using the proteins differentially expressed at least
at one time point in our treatment we calculated the optimal number of clusters
using the “clusGap” in R. Based on that result, k-means clustering was performed
using the function “cluster_analysis” from the library “multiClust” in R.
In all boxplot representations center lines show the medians; box limits indicate
the 25th and 75th percentiles as determined by R software; whiskers extend 1.5
times the interquartile range from the 25th and 75th percentiles, outliers are
represented by dots.
Functional annotation. Functional annotation of proteins was performed using
either ClueGO, StringDB, or GSEA, using in all cases FDR control <5%. Potential
kinase motifs were annotated using Perseus for class I phosphorylation sites.
Fisher’s exact test was performed to determine which motifs were significantly
represented in each cluster. The background used for the enrichment analysis was
comprised of all the class I phosphosites in the data (13,593 sites).
Re-analysis of published transcriptomics data. Processed data from the fol-
lowing selected publications was used in the current publication: Bulut-Karslioglu
et al.16 (GSE81285), Marks et al.5 (GSE23943), Buecker et al.59 (GSE56138),
Kolodziejczyk et al.75 (E-MTAB-2600), Fidalgo et al.76 (GSE81045), and Lynch
et al.3 (GSE112208). Data was either downloaded directly from GEO repository or,
if available, from Supplementary Material from the publication. Processed tran-
script instensities were log2 transformed and normalized by “Loess” (from limma
package in R). Afterwards, differential genes between Naïve and Serum/LIF
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conditions were estimated using the workflow “GEO2R” (https://www.ncbi.nlm.
nih.gov/geo/geo2r/). Transcripts were considered significant if their fold change
was above or below 1 (in log2 scale) and the p-value corrected by
Benjamini–Hochberg was below 0.05. Upregulated and downregulated transcripts
in 2i were used as gene-sets to perform rank-based enrichment analysis using
GSEA algorithm. Ranked list of protein ratios in log2 at each time point of
treatment was used as input for GSEA. GSEA was performed using default values.
Normalized enrichment score was employed as scoring system.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE partner repository with the dataset identifier PXD018694. The
mass spectrometry metabolomics data have been deposited to the Metabolights database
with the identifier MTBLS301. Processed data from the following selected publications
were used in the current publication: Bulut-Karslioglu et al.16 (GSE81285), Marks et al.5
(GSE23943), Buecker et al.59 (GSE56138), Kolodziejczyk et al.75 (E-MTAB-2600),
Fidalgo et al.76 (GSE81045), and Lynch et al.3 (GSE112208). Source data are provided
with this paper.
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